Supplementary Figure 4 from Immune Consequences of Decreasing Tumor Vasculature with Antiangiogenic Tyrosine Kinase Inhibitors in Combination with Therapeutic Vaccines

Abstract

<p>Sunitinib alone or in combination with vaccine decreased the frequency of splenic MDSCs and monocytes in tumor bearing mice.</p>